๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Enhanced efficacy of chloroquine-chlorpheniramine combination in acute uncomplicated falciparum malaria in children

โœ Scribed by A. Sowunmi; A.M.J. Oduola; O.A.T. Ogundahunsi; C.O. Falade; G.O. Gbotosho; L.A. Salako


Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
695 KB
Volume
91
Category
Article
ISSN
0035-9203

No coin nor oath required. For personal study only.

โœฆ Synopsis


Chlorpheniramine, a histamine HI receptor antagonist, reverses chloroquine resistance in Plasmodium falciaarum in vitro. However. the clinical sianificance of this remains unclear. We have evaluated the efficacv of chloroquine and a chloroquine-chlorbheniramine combination in 112 consecutive children with acute symptomatic uncomplicated falciparum malaria. There was no significant difference in the parasite and fever clearance times in the 2 treatment groups. However, the proportion of patients in whom parasitaemia increased 24 h after commencement of treatment was significantly higher in the chloroquine group than in the chloroquine-chlorpheniramine group (285% vs. 8.3%,x2=6.61, PcO.01). There was also a higher proportion of children with RI1 and RI11 responses to treatment in the chloroquine than in the chloroquine-chlorpheniramine group but the difference was not statistically significant. The cure rate on day 14 was higher in the chloroquine-chlorpheniramine group than in the chloroquine group. Chloroquine and its combination with chlorpheniramine were well tolerated, the only prominent adverse effect being pruritus, with equal incidence in both groups. Chlorpheniramine reversed chloroquine resistance in vitro in a similar manner to verapamil in isolates of I? falciparum obtained from the patients. Failure of a response in vivo to chloroquine correlated with resistance in vitro in patients treated with this drug. In contrast, all but one patient with isolates which were chloroquine resistant in vitro were successfully treated with chloroquine-chlorpheniramine combination. These data suggest the enhanced efficacy of chloroquine-chlorpheniramine combination in treating acute uncomplicated l? falciparum infection in children from an endemic area of Nigeria.


๐Ÿ“œ SIMILAR VOLUMES


Comparative efficacy of chloroquine plus
โœ A. Sowunmi; F.A. Fehintola; O.A.T. Ogundahunsi; A.M.J. Oduola ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 683 KB

In the face of growing chloroquine resistance of Plasmodium falciparum, efforts to prolong the clinical usefulness of the drug have partly concentrated on its combination with potential resistance-reversing compounds. However, clinical studies on such combinations have been limited. We have compared

Comparative efficacy of chloroquine plus
โœ A. Sowunmi; A.M.J. Oduola; O.A.T. Ogundahunsi; L.A. Salako ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 647 KB

The efficacy of pyrimethamineisulfadoxine (I'S) and chloroquine plus chlorpheniramine, a histamine H1 receptor blocker which reverses chloroquine insensitivity in Plasmodium falciparum in vitro, was evaluated in 100 consecutive children with acute symptomatic uncomplicated falciparum malaria. Parasi

Comparative cardiac effects of halofantr
โœ A. Sowunmi; F.A. Fehintola; O.A.T. Ogundahunsi; A.B. Ofi; T.C. Happi; A.M.J. Odu ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 791 KB

The cardiac effects ofhalofantrine (HF) and chloroquine plus chlorpheniramine (CQ-CP), a histamine Hi antagonist which reverses chloroquine insensitivity in Plasmodium falciparum in vitro and in vivo, were assessed in 41 children with acute svmntomatic uncomnlicated P fa&arum malaria bv electrocardi